PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Combination approach shows promise for treating rare, aggressive cancers

UCLA research finds that combining immunotherapy with chemotherapy is safe and effective for people with advanced small cell cancers in the bladder and prostate

2024-11-12
(Press-News.org) A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell/neuroendocrine prostate cancer.

Small cell carcinomas can arise in various tissues—including the bladder, prostate, lung, ovaries and breast—and are known for their rapid progression, tendency to relapse after initial treatment and poor overall survival rates. The survival time for patients with advanced small cell bladder cancer is only about 7 to 13 months and only 7 to 9 months for patients with small cell/neuroendocrine prostate cancer.

The early-stage study, published in Cell Reports Medicine, showed that using pembrolizumab with chemotherapy resulted in 43% of patients having a partial or complete regression of disease, with 86% of patients with bladder cancer and 57% of those with small cell/neuroendocrine prostate cancer living two years. 

“The combination of pembrolizumab and chemotherapy presents a promising new treatment approach for these challenging-to-treat, rare cancers and could be a major breakthrough for patient care,” said Dr. Arnold Chin, professor of urology at the David Geffen School of Medicine at UCLA and senior author of the study.

Immune-based treatment, such as pembrolizumab, has showed success for treating people with a variety of advanced or metastatic cancers, including patients with advanced small cell lung cancer. Previous laboratory-based research at UCLA, led by Dr. Owen Witte, Chin and colleagues, has demonstrated that small cell cancers in the bladder, lung, and prostate share many biological traits. Building on these findings, Chin and his team pursued the concept that treatment approaches should target cancers based on molecular similarities. They designed a clinical trial across all small cell/neuroendocrine urologic cancers combining pembrolizumab and chemotherapy as a first-line therapy for bladder and prostate small cell cancers.

The trial involved 15 patients who were separated into two cohorts. The first included seven participants with advanced or metastatic small cell bladder cancer, while the other group included eight patients with primary small cell or neuroendocrine prostate cancer. The study was designed for patients who would normally receive chemotherapy as part of their standard care.

The researchers found that patients showed favorable responses using this treatment regimen. In bladder cancer group, only one out of seven patients experienced disease progression after a median follow up of almost three years.

For the prostate cancer group, the median survival for patients with small cell/neuroendocrine prostate cancer in the trial reached 27 months, which is longer than expected compared to the historical average of just 7 to 9 months.

The combination treatment was also well-tolerated, with no patients needing to stop therapy due to side effects.

“These results suggests that the combination therapy could provide a substantial survival benefit,” said Chin, who is a member of the UCLA Health Jonsson Comprehensive Cancer Center and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research.

Along with the encouraging survival rates, the team found that the clonal expansion of CD8+ T cells in the blood, a type of immune cell, in response to treatment correlated with better progression-free survival. This indicated that a blood test could be predictive of treatment response for patients in the future.

The findings support the need for larger clinical trials to confirm these findings.

The study’s first authors are Yiqian Gu, a graduate student in the bioinformatics interdepartmental program at UCLA, and Ann Ly, formerly a staff researcher in the department of urology at UCLA and now a doctoral candidate at UC Davis. UCLA authors include Sara Rodriquez, Hanwei Zhang, Jiyoon Kim, Zhiyuan Mao, Ankush Sachdeva, Nazy Zomorodian, Matteo Pellegrini, Gang Li, Alexandra Drakaki, Matthew Rettig, and Sandy Liu, who is now at City of Hope.

END


ELSE PRESS RELEASES FROM THIS DATE:

Raise the roof: How to reduce badminton birdie drift

Raise the roof: How to reduce badminton birdie drift
2024-11-12
WASHINGTON, Nov. 12, 2024 – Indoor badminton courts are often used for high-stakes tournaments, but even an enclosed court can affect the path of a birdie. The airflow from a court’s heating, ventilation, and air conditioning (HVAC) system and cross ventilation plays a significant role in badminton. The lightweight feathered birdie passed between the players can be affected by low wind speed in the stadium. This is known as wind drift and has been at the center of multiple tournament controversies. While shutting ...

Ouch! Commonalties found in pain vocalizations and interjections across cultures

Ouch! Commonalties found in pain vocalizations and interjections across cultures
2024-11-12
WASHINGTON, Nov. 12, 2024 – There are an estimated 7,000 languages spoken worldwide, each offering unique ways to express human emotion. But do certain emotions show regularities in their vocal expression across languages? In JASA, published on behalf of the Acoustical Society of America by AIP Publishing, an interdisciplinary team of linguists and bioacousticians led by Maïa Ponsonnet, Katarzyna Pisanski, and Christophe Coupé explored this by comparing expressive interjections (like “wow!”) ...

Income-related disparities in mortality among young adults with type 2 diabetes

2024-11-12
About The Study: In this cohort study of 1.2 million individuals ages 20 to 79 in South Korea, the risk of mortality with low income was most prominent among individuals with type 2 diabetes ages 20 to 39. These findings highlight the need for socioeconomic support to reduce income-related health disparities in younger individuals. Corresponding authors: To contact the corresponding authors, email Sin Gon Kim, MD, PhD (k50367@korea.ac.kr) and Nam Hoon Kim, MD, PhD (pourlife@korea.ac.kr). To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi: ...

Medical board discipline of physicians for spreading medical misinformation

2024-11-12
About The Study: The frequency of discipline for physician-spread misinformation observed in this cross-sectional study was quite low despite increased salience and medical board warnings since the start of the COVID-19 pandemic about the dangers of physicians spreading falsehoods. These findings suggest a serious disconnect between regulatory guidance and enforcement and call into question the suitability of licensure regulation for combatting physician-spread misinformation. Corresponding author: To contact the corresponding author, Richard S. Saver, J.D., ...

First-ever randomized clinical trial uses telehealth for suicide prevention

First-ever randomized clinical trial uses telehealth for suicide prevention
2024-11-12
COLUMBUS, Ohio – Suicide remains a pressing public health concern. An estimated 703,000 people die by suicide each year worldwide, according to The World Health Organization. In 2022, there were 49,449 suicides in the United States.  A new study found that brief cognitive behavioral therapy for suicide prevention – when delivered remotely via video telehealth – reduces suicide attempts and suicidal ideation. Researchers at The Ohio State University Wexner Medical Center and College of Medicine led the study that is published online in the journal JAMA Network Open. The randomized clinical ...

DNA packaging directly affects how fast DNA is copied in cells

2024-11-12
Researchers from the Mattiroli group have found that the way DNA is packaged in cells can directly impact how fast DNA itself is copied during cell division. They discovered that DNA packaging sends signals through an unusual pathway, affecting the cell’s ability to divide and grow. This opens up new doors to study how the copying of the DNA and its packaging are linked. These findings, published in Molecular Cell, may help scientists to find therapies and medicines for diseases such as cancer in the future. Chromatin as a guide Every day, our cells divide. Each time they need to copy both their DNA and the structure in which the DNA is packed. This packaging, ...

Scientists develop advanced catalyst for self-driven seawater splitting with enhanced chloride resistance

2024-11-12
Seawater electrolysis has long been seen as a promising pathway for sustainable hydrogen production but has faced significant limitations due to chloride ion (Cl⁻) corrosion, which can degrade a catalyst's performance. Now scientists from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences, along with their collaborators, have developed an efficient electrocatalyst called Co-N/S-HCS that demonstrates remarkable activity and stability in ...

City of Hope researchers discover why taking a mushroom supplement slows or prevents prostate cancer from getting worse

City of Hope researchers discover why taking a mushroom supplement slows or prevents prostate cancer from getting worse
2024-11-12
LOS ANGELES — Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, ranked among the nation’s top 5 cancer centers by U.S. News & World Report and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, now understand why taking an investigational white button mushroom supplement shows promise in slowing and even preventing prostate cancer from spreading among men who joined ...

Montefiore Einstein’s Marina Konopleva joins Break Through Cancer TeamLab in fight against acute myelogenous leukemia

Montefiore Einstein’s Marina Konopleva joins Break Through Cancer TeamLab in fight against acute myelogenous leukemia
2024-11-12
November 12, 2024—(BRONX, NY)— Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world’s deadliest cancers. Dr. Konopleva will play a pivotal role in the Eradicating Minimal Residual Disease (MRD) in Acute ...

Early treatment for nerve tumors prevents serious problems, study finds

Early treatment for nerve tumors prevents serious problems, study finds
2024-11-12
Patients with a small cranial nerve tumor that can cause hearing loss, vertigo, imbalance and ringing in the ears have typically been watched rather than proactively treated, as the risks of early intervention were thought to outweigh the benefits. However, even those patients benefit significantly from non-invasive stereotactic radiosurgery, a multicenter, international study led by UVA Health physicians has found. Doctors typically treat larger forms of the tumors, called vestibular schwannomas, while taking a “watch and wait” approach ...

LAST 30 PRESS RELEASES:

Unlocking the mysteries of the human gut

High-quality nanodiamonds for bioimaging and quantum sensing applications

New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia

Evolution of fast-growing fish-eating herring in the Baltic Sea

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

[Press-News.org] Combination approach shows promise for treating rare, aggressive cancers
UCLA research finds that combining immunotherapy with chemotherapy is safe and effective for people with advanced small cell cancers in the bladder and prostate